| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 1,902,659 | $11,796,486 | $6.20 | 13 Feb 2024 | By Trust |
| Telomir Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 1,365,646 | $8,467,005 | $6.20 | 13 Feb 2024 | Indirect |
| Telomir Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 24,391 | $151,224 | $6.20 | 13 Feb 2024 | Direct |
| Telomir Pharmaceuticals, Inc. | 10%+ Owner | Common Stock (right to buy) | 2,339,025 | 21 Nov 2024 | By Trust | ||
| MIRA PHARMACEUTICALS, INC. | 10%+ Owner | Common Stock Warrant (right to buy) | 700,000 | 15 Nov 2023 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TELO | Telomir Pharmaceuticals, Inc. | 21 Nov 2024 | 1 | $0 | 4 | 10%+ Owner | 25 Nov 2024, 17:06 |
| TELO | Telomir Pharmaceuticals, Inc. | 13 Feb 2024 | 3 | +$966,000 | 4 | 10%+ Owner | 15 Feb 2024, 16:11 |
| TELO | Telomir Pharmaceuticals, Inc. | 08 Feb 2024 | 0 | $0 | 3 | 10%+ Owner | 08 Feb 2024, 18:01 |
| MIRA | MIRA PHARMACEUTICALS, INC. | 15 Nov 2023 | 1 | $0 | 4 | 10%+ Owner | 17 Nov 2023, 17:09 |